Clinical Trial Update: Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study [NA]

View source ↗

Summary

This is a completed pilot trial investigating marrow-derived mesenchymal cell therapy for osteogenesis imperfecta. The study was sponsored by St. Jude Children'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Marrow Mesenchymal Cell Therapy

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Osteogenesis Imperfecta | NA | Status: COMPLETED